VYNE Therapeutics Insider Sales Surge Ahead of Yarrow Merger Vote, Raising Confidence Flags for Investors
Insider selling at VYNE Therapeutics may signal skepticism ahead of a Yarrow Bioscience merger—could it be a tactical move or warning?
3 minutes to read